Search results

Sourcing decisions are one of the most crucial strategic decisions in companies and often confronted with inherent unexpected uncertainties and risks. This study aims to investigate the impact of ownership involvement on purchasing (PUR) supplier selection activities, including risk consideration in family firms (FFs).

The investigation is based on a structured literature review (SLR) of 83 studies to identify FF-specific supplier sourcing characteristics. To verify these propositions, the authors conducted a second SLR of non-FF behaviour research (179 papers) to generate a non-FF reference base for the respective behavioural characteristics. Following this analysis, the authors conducted 16 qualitative and explorative-oriented expert interviews (EIs).

Based on reviews, the authors deduce that PUR activities of family and non-FFs are different regarding the PUR decision processes and PUR risk behaviour, and that suppliers' selection criteria like sustainability, partnership and long-term orientation are prioritised in FFs. Additionally, several trends of family and non-FF behaviour approximation were identified. Besides these findings, it might be expected that the differentiating characteristics of family and non-FFs vary based on their region or industry sector. The EIs indicated that “the depth of added values” should be considered as a further potential differentiating influence factor.

The analysis encourages to execute further quantitative studies on FF sourcing activities and requests managers to strengthen the position of the PUR departments in FFs.

The aim of this study is to critically examine the transparency and reporting practice of Environmental, Social, and Governance (ESG) controversies within the pharmaceutical and textile industry. Based on the four core dimensions of transparency, we explore which reporting medium is most frequently chosen for the disclosure of negative ESG contributions, the nature and information content of the disclosed incidents and how voluntary adherence to sustainability reporting standards and independent assurances affect the reporting.

We use conceptual content analysis and employ a counter-accounting approach to analyse the disclosure of 190 ESG controversies in 104 corporate reports from the pharmaceutical and textile industries, covering a three-year period from 2018–2020.

The very large majority of controversies are reported only once in the legal proceedings section of the annual report, but not again in the sustainability report, where it would be necessary to provide a balanced picture. Moreover, companies tend to disclose only those controversies that are either associated with high media attention or are expected to be related to litigation, resulting in 26 per cent of controversies not being disclosed at all. The overall quality of disclosure is unsatisfactory and in need of improvement, but comparably higher in the pharmaceutical industry than in the textile industry. Interestingly, neither the application of sustainability reporting standards nor independent assurance seems to positively impact the disclosure behaviour.

Our paper provides new insights into the shortcomings of current ESG controversy disclosures by revealing patterns of selective reporting practices and the strategic framing of issues. In addition, it contributes to the debates on corporate cherry-picking in the adoption of sustainability reporting guidelines and on the effectiveness of external assurance of sustainability reports. Based on the findings, it offers important implications for practitioners, in particular management, policy makers, rating agencies and assurance providers.